CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,117 enrolled
Drug / intervention
Text-Messaging (TM) +2 morebehavioral
Likely dose
Not stated in record
Key inclusion· 4
  • Current patient of a participating community health center
  • Have a working cellphone
  • Have phone number listed in existing electronic medical record at their participating clinic
  • Speak English or Spanish
Key exclusion· 1
  • Minors (age <18)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05533359
NCT05533359N/ACompleted

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Testing and Vaccination Among Utah Community Health Centers

University of Utah·interventional·Posted Sep 9, 2022·Updated Jan 15, 2025

In Brief

A clinical study evaluating Text-Messaging (TM), Conversational Agent (CA), and 1 other intervention for COVID-19. Completed, enrolled 2,117 participants across 1 site.

Detailed Summary

The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021 to increase the uptake of COVID-19 testing and vaccination among community health center patients. Interventions are based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II will both build on SCALE-UP Utah PHM interventions and investigate novel resource conservation approaches (i.e., Request-Patient Navigation vs. No Patient Navigation and text messaging vs. conversational agent). SCALE-UP II builds on long standing partnerships among the University of Utah Clinical and Translational Science Institute (UofU CTSI), Association for Utah Community Health (AUCH), CHCs, and the Utah Department of Health(UDOH). CTSI and SCALE-UP II investigators are leading several COVID-19 initiatives that drive public health response and state government policies in Utah. Thus, the UofU team is uniquely positioned to lead this project.

Study Details

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 9, 2022
Enrollment StartJan 15, 2023
Primary CompletionNov 30, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.8 years ago

Interventions

Text-Messaging (TM)behavioral

Participants in the TM condition will receive HIPAA-compliant bidirectional text messages. These texts will include a brief message alerting patients that they are eligible to receive a test kit and asking participants if they would like to receive a test kit. Participants who reply "yes" will receive an additional message with information about how to receive a test kit.

Conversational Agent (CA)behavioral

Patients in the CA condition will receive a link to an automated, scripted and interactive conversational agent used to mimic human interaction to: 1) elicit specific hesitancy factors and barriers to testing; 2) provide tailored information to address each individual's hesitancy factors and barriers to testing; and 3) offer access to at-home rapid test kits.

Patient Navigation (PN)behavioral

Participants in the PN condition will receive a call from a Community Health Worker to assist with the process of receiving a COVID test. At this time the participant has the option to opt-out of this follow up phone call. The patient navigation from the Community Health Worker includes practical advice in addressing barriers to testing such as logistics, as well as fear, skepticism, and hesitancy. There are two distinct different types of patient navigation. A person can be randomly assigned to either type, or no PN, or a combination of the two types.